Cargando…

Lipid nanostructures for targeting brain cancer

Advancements in both material science and bionanotechnology are transforming the health care sector. To this end, nanoparticles are increasingly used to improve diagnosis, monitoring, and therapy. Huge research is being carried out to improve the design, efficiency, and performance of these nanopart...

Descripción completa

Detalles Bibliográficos
Autores principales: Nsairat, Hamdi, Khater, Dima, Odeh, Fadwa, Al-Adaileh, Fedaa, Al-Taher, Suma, Jaber, Areej M., Alshaer, Walhan, Al Bawab, Abeer, Mubarak, Mohammad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488847/
https://www.ncbi.nlm.nih.gov/pubmed/34632135
http://dx.doi.org/10.1016/j.heliyon.2021.e07994
_version_ 1784578235216953344
author Nsairat, Hamdi
Khater, Dima
Odeh, Fadwa
Al-Adaileh, Fedaa
Al-Taher, Suma
Jaber, Areej M.
Alshaer, Walhan
Al Bawab, Abeer
Mubarak, Mohammad S.
author_facet Nsairat, Hamdi
Khater, Dima
Odeh, Fadwa
Al-Adaileh, Fedaa
Al-Taher, Suma
Jaber, Areej M.
Alshaer, Walhan
Al Bawab, Abeer
Mubarak, Mohammad S.
author_sort Nsairat, Hamdi
collection PubMed
description Advancements in both material science and bionanotechnology are transforming the health care sector. To this end, nanoparticles are increasingly used to improve diagnosis, monitoring, and therapy. Huge research is being carried out to improve the design, efficiency, and performance of these nanoparticles. Nanoparticles are also considered as a major area of research and development to meet the essential requirements for use in nanomedicine where safety, compatibility, biodegradability, biodistribution, stability, and effectiveness are requirements towards the desired application. In this regard, lipids have been used in pharmaceuticals and medical formulations for a long time. The present work focuses on the use of lipid nanostructures to combat brain tumors. In addition, this review summarizes the literature pertaining to solid lipid nanoparticles (SLN) and nanostructured lipid carriers (LNC), methods of preparation and characterization, developments achieved to overcome blood brain barrier (BBB), and modifications used to increase their effectiveness.
format Online
Article
Text
id pubmed-8488847
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84888472021-10-08 Lipid nanostructures for targeting brain cancer Nsairat, Hamdi Khater, Dima Odeh, Fadwa Al-Adaileh, Fedaa Al-Taher, Suma Jaber, Areej M. Alshaer, Walhan Al Bawab, Abeer Mubarak, Mohammad S. Heliyon Review Article Advancements in both material science and bionanotechnology are transforming the health care sector. To this end, nanoparticles are increasingly used to improve diagnosis, monitoring, and therapy. Huge research is being carried out to improve the design, efficiency, and performance of these nanoparticles. Nanoparticles are also considered as a major area of research and development to meet the essential requirements for use in nanomedicine where safety, compatibility, biodegradability, biodistribution, stability, and effectiveness are requirements towards the desired application. In this regard, lipids have been used in pharmaceuticals and medical formulations for a long time. The present work focuses on the use of lipid nanostructures to combat brain tumors. In addition, this review summarizes the literature pertaining to solid lipid nanoparticles (SLN) and nanostructured lipid carriers (LNC), methods of preparation and characterization, developments achieved to overcome blood brain barrier (BBB), and modifications used to increase their effectiveness. Elsevier 2021-09-16 /pmc/articles/PMC8488847/ /pubmed/34632135 http://dx.doi.org/10.1016/j.heliyon.2021.e07994 Text en © 2021 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Nsairat, Hamdi
Khater, Dima
Odeh, Fadwa
Al-Adaileh, Fedaa
Al-Taher, Suma
Jaber, Areej M.
Alshaer, Walhan
Al Bawab, Abeer
Mubarak, Mohammad S.
Lipid nanostructures for targeting brain cancer
title Lipid nanostructures for targeting brain cancer
title_full Lipid nanostructures for targeting brain cancer
title_fullStr Lipid nanostructures for targeting brain cancer
title_full_unstemmed Lipid nanostructures for targeting brain cancer
title_short Lipid nanostructures for targeting brain cancer
title_sort lipid nanostructures for targeting brain cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488847/
https://www.ncbi.nlm.nih.gov/pubmed/34632135
http://dx.doi.org/10.1016/j.heliyon.2021.e07994
work_keys_str_mv AT nsairathamdi lipidnanostructuresfortargetingbraincancer
AT khaterdima lipidnanostructuresfortargetingbraincancer
AT odehfadwa lipidnanostructuresfortargetingbraincancer
AT aladailehfedaa lipidnanostructuresfortargetingbraincancer
AT altahersuma lipidnanostructuresfortargetingbraincancer
AT jaberareejm lipidnanostructuresfortargetingbraincancer
AT alshaerwalhan lipidnanostructuresfortargetingbraincancer
AT albawababeer lipidnanostructuresfortargetingbraincancer
AT mubarakmohammads lipidnanostructuresfortargetingbraincancer